Use of video-recordings of site-based interviews for quality assurance in a study of subjects with schizophrenia and persistent negative symptoms

Site-independent ratings derived from audio-digital recordings of site-based interviews are often used for quality assurance monitoring to affirm ratings reliability in CNS clinical trials. The present study of subjects with schizophrenia and persistent negative symptoms used video instead of audio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Schizophrenia research Jg. 272; S. 61 - 68
Hauptverfasser: Targum, Steven D., Ge, Tingting, Asgharnejad, Mahnaz, Reksoprodjo, Petra, Singh, Jaskaran B., Murthy, Venkatesha
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Netherlands Elsevier B.V 01.10.2024
Schlagworte:
ISSN:0920-9964, 1573-2509, 1573-2509
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Site-independent ratings derived from audio-digital recordings of site-based interviews are often used for quality assurance monitoring to affirm ratings reliability in CNS clinical trials. The present study of subjects with schizophrenia and persistent negative symptoms used video instead of audio recordings of site-based interviews and thereby facilitated visual observation of the subject by the remote rater. “Paired” site-independent scores of the Positive and Negative Syndrome Scale (PANSS) and Brief Negative Symptom Scale (BNSS) were obtained from video-recordings of site-based interviews. The intraclass correlation between site-based and paired site-independent ratings was r = 0.839 for the total PANSS scores (n = 1006) and r = 0.871 for the total BNSS scores (n = 892); <5 % of paired scores deviated outside the acceptable confidence intervals. Ratings “outliers” were identified and remediated. We examined the pattern of paired scoring deviations for the BNSS, total PANSS, PANSS symptom subscales, and the Marder negative symptom factor. Each metric revealed a bidirectional pattern of scoring deviations such that mean site-based ratings were higher than site-independent ratings when symptom severity was high but lower than site-independent ratings when symptom severity was low. The pattern of bidirectional paired scoring deviations observed in this analysis has previously been noted in paired ratings analyses of subjects experiencing an acute exacerbation of psychosis in schizophrenia and major depressive disorder as well. The bidirectional pattern may reflect inherent differences between live ratings and remotely scored recorded ratings. This analysis affirms the utility of video-recordings of site-based ratings for surveillance in trials with subjects with schizophrenia and persistent negative symptoms.
AbstractList Site-independent ratings derived from audio-digital recordings of site-based interviews are often used for quality assurance monitoring to affirm ratings reliability in CNS clinical trials. The present study of subjects with schizophrenia and persistent negative symptoms used video instead of audio recordings of site-based interviews and thereby facilitated visual observation of the subject by the remote rater. "Paired" site-independent scores of the Positive and Negative Syndrome Scale (PANSS) and Brief Negative Symptom Scale (BNSS) were obtained from video-recordings of site-based interviews. The intraclass correlation between site-based and paired site-independent ratings was r = 0.839 for the total PANSS scores (n = 1006) and r = 0.871 for the total BNSS scores (n = 892); <5 % of paired scores deviated outside the acceptable confidence intervals. Ratings "outliers" were identified and remediated. We examined the pattern of paired scoring deviations for the BNSS, total PANSS, PANSS symptom subscales, and the Marder negative symptom factor. Each metric revealed a bidirectional pattern of scoring deviations such that mean site-based ratings were higher than site-independent ratings when symptom severity was high but lower than site-independent ratings when symptom severity was low. The pattern of bidirectional paired scoring deviations observed in this analysis has previously been noted in paired ratings analyses of subjects experiencing an acute exacerbation of psychosis in schizophrenia and major depressive disorder as well. The bidirectional pattern may reflect inherent differences between live ratings and remotely scored recorded ratings. This analysis affirms the utility of video-recordings of site-based ratings for surveillance in trials with subjects with schizophrenia and persistent negative symptoms.
AbstractSite-independent ratings derived from audio-digital recordings of site-based interviews are often used for quality assurance monitoring to affirm ratings reliability in CNS clinical trials. The present study of subjects with schizophrenia and persistent negative symptoms used video instead of audio recordings of site-based interviews and thereby facilitated visual observation of the subject by the remote rater. “Paired” site-independent scores of the Positive and Negative Syndrome Scale (PANSS) and Brief Negative Symptom Scale (BNSS) were obtained from video-recordings of site-based interviews. The intraclass correlation between site-based and paired site-independent ratings was r = 0.839 for the total PANSS scores ( n = 1006) and r = 0.871 for the total BNSS scores ( n = 892); <5 % of paired scores deviated outside the acceptable confidence intervals. Ratings “outliers” were identified and remediated. We examined the pattern of paired scoring deviations for the BNSS, total PANSS, PANSS symptom subscales, and the Marder negative symptom factor. Each metric revealed a bidirectional pattern of scoring deviations such that mean site-based ratings were higher than site-independent ratings when symptom severity was high but lower than site-independent ratings when symptom severity was low. The pattern of bidirectional paired scoring deviations observed in this analysis has previously been noted in paired ratings analyses of subjects experiencing an acute exacerbation of psychosis in schizophrenia and major depressive disorder as well. The bidirectional pattern may reflect inherent differences between live ratings and remotely scored recorded ratings. This analysis affirms the utility of video-recordings of site-based ratings for surveillance in trials with subjects with schizophrenia and persistent negative symptoms.
Site-independent ratings derived from audio-digital recordings of site-based interviews are often used for quality assurance monitoring to affirm ratings reliability in CNS clinical trials. The present study of subjects with schizophrenia and persistent negative symptoms used video instead of audio recordings of site-based interviews and thereby facilitated visual observation of the subject by the remote rater. "Paired" site-independent scores of the Positive and Negative Syndrome Scale (PANSS) and Brief Negative Symptom Scale (BNSS) were obtained from video-recordings of site-based interviews. The intraclass correlation between site-based and paired site-independent ratings was r = 0.839 for the total PANSS scores (n = 1006) and r = 0.871 for the total BNSS scores (n = 892); <5 % of paired scores deviated outside the acceptable confidence intervals. Ratings "outliers" were identified and remediated. We examined the pattern of paired scoring deviations for the BNSS, total PANSS, PANSS symptom subscales, and the Marder negative symptom factor. Each metric revealed a bidirectional pattern of scoring deviations such that mean site-based ratings were higher than site-independent ratings when symptom severity was high but lower than site-independent ratings when symptom severity was low. The pattern of bidirectional paired scoring deviations observed in this analysis has previously been noted in paired ratings analyses of subjects experiencing an acute exacerbation of psychosis in schizophrenia and major depressive disorder as well. The bidirectional pattern may reflect inherent differences between live ratings and remotely scored recorded ratings. This analysis affirms the utility of video-recordings of site-based ratings for surveillance in trials with subjects with schizophrenia and persistent negative symptoms.Site-independent ratings derived from audio-digital recordings of site-based interviews are often used for quality assurance monitoring to affirm ratings reliability in CNS clinical trials. The present study of subjects with schizophrenia and persistent negative symptoms used video instead of audio recordings of site-based interviews and thereby facilitated visual observation of the subject by the remote rater. "Paired" site-independent scores of the Positive and Negative Syndrome Scale (PANSS) and Brief Negative Symptom Scale (BNSS) were obtained from video-recordings of site-based interviews. The intraclass correlation between site-based and paired site-independent ratings was r = 0.839 for the total PANSS scores (n = 1006) and r = 0.871 for the total BNSS scores (n = 892); <5 % of paired scores deviated outside the acceptable confidence intervals. Ratings "outliers" were identified and remediated. We examined the pattern of paired scoring deviations for the BNSS, total PANSS, PANSS symptom subscales, and the Marder negative symptom factor. Each metric revealed a bidirectional pattern of scoring deviations such that mean site-based ratings were higher than site-independent ratings when symptom severity was high but lower than site-independent ratings when symptom severity was low. The pattern of bidirectional paired scoring deviations observed in this analysis has previously been noted in paired ratings analyses of subjects experiencing an acute exacerbation of psychosis in schizophrenia and major depressive disorder as well. The bidirectional pattern may reflect inherent differences between live ratings and remotely scored recorded ratings. This analysis affirms the utility of video-recordings of site-based ratings for surveillance in trials with subjects with schizophrenia and persistent negative symptoms.
Site-independent ratings derived from audio-digital recordings of site-based interviews are often used for quality assurance monitoring to affirm ratings reliability in CNS clinical trials. The present study of subjects with schizophrenia and persistent negative symptoms used video instead of audio recordings of site-based interviews and thereby facilitated visual observation of the subject by the remote rater. “Paired” site-independent scores of the Positive and Negative Syndrome Scale (PANSS) and Brief Negative Symptom Scale (BNSS) were obtained from video-recordings of site-based interviews. The intraclass correlation between site-based and paired site-independent ratings was r = 0.839 for the total PANSS scores (n = 1006) and r = 0.871 for the total BNSS scores (n = 892); <5 % of paired scores deviated outside the acceptable confidence intervals. Ratings “outliers” were identified and remediated. We examined the pattern of paired scoring deviations for the BNSS, total PANSS, PANSS symptom subscales, and the Marder negative symptom factor. Each metric revealed a bidirectional pattern of scoring deviations such that mean site-based ratings were higher than site-independent ratings when symptom severity was high but lower than site-independent ratings when symptom severity was low. The pattern of bidirectional paired scoring deviations observed in this analysis has previously been noted in paired ratings analyses of subjects experiencing an acute exacerbation of psychosis in schizophrenia and major depressive disorder as well. The bidirectional pattern may reflect inherent differences between live ratings and remotely scored recorded ratings. This analysis affirms the utility of video-recordings of site-based ratings for surveillance in trials with subjects with schizophrenia and persistent negative symptoms.
Author Asgharnejad, Mahnaz
Singh, Jaskaran B.
Targum, Steven D.
Ge, Tingting
Reksoprodjo, Petra
Murthy, Venkatesha
Author_xml – sequence: 1
  givenname: Steven D.
  surname: Targum
  fullname: Targum, Steven D.
  email: sdtargum@yahoo.com
  organization: Signant Health, United States of America
– sequence: 2
  givenname: Tingting
  surname: Ge
  fullname: Ge, Tingting
  organization: Neurocrine Biosciences Inc, United States of America
– sequence: 3
  givenname: Mahnaz
  surname: Asgharnejad
  fullname: Asgharnejad, Mahnaz
  organization: Takeda Pharmaceuticals Ltd, United States of America
– sequence: 4
  givenname: Petra
  surname: Reksoprodjo
  fullname: Reksoprodjo, Petra
  organization: Signant Health, United States of America
– sequence: 5
  givenname: Jaskaran B.
  surname: Singh
  fullname: Singh, Jaskaran B.
  organization: Neurocrine Biosciences Inc, United States of America
– sequence: 6
  givenname: Venkatesha
  surname: Murthy
  fullname: Murthy, Venkatesha
  organization: Takeda Pharmaceuticals Ltd, United States of America
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39190983$$D View this record in MEDLINE/PubMed
BookMark eNqVUstuFDEQtFAQ2QT-ACEfuczStucpISQU8ZIicYCcLY_dk3iZtTduT6LlL_hjvGzghhC-WHJXlbur-oydhBiQsecC1gJE-2qzJnuTkNYSZL2Gfg2ifsRWoulUJRsYTtgKBgnVMLT1KTsj2gCAaKB7wk7VIAYYerViP64IeZz4nXcYq4Q2JufDNR3eyGesRkPouA8Z053He-JTTPx2MbPPe26IlmSCxQLghlNe3P4Xcxk3aDPxe59veOnTf4-70mzwhpvg-A4TecoYMg94bbK_Q0777S7HLT1ljyczEz57uM_Z1ft3Xy8-VpefP3y6eHtZ2bptcmVwtJMD1WE_udapckYpXa86UZtatv1QhlTYylLqrJAdjBOWUtNM1k6yUefs5VF3l-LtgpT11pPFeTYB40JawdD1DahBFeiLB-gybtHpXfJbk_b6t40FUB8BNkWihNMfiAB9SEtv9DEtfUhLQ69LWoX25kjDMmdxNxWQx2Kn8yWJrF30_ytgZx-8NfM33CNt4pJC8VALTVKD_nJYiMM-yBpA9Y0sAq__LvDv_38CfuzLtg
Cites_doi 10.1016/j.schres.2024.06.017
10.1016/j.conctc.2019.100317
10.1016/j.pnpbp.2016.02.007
10.1016/j.jpsychires.2013.02.016
10.4088/JCP.v58n1205
10.1097/JCP.0000000000000422
10.1016/j.euroneuro.2014.08.016
10.1001/jama.2013.281053
10.1016/j.jpsychires.2019.01.017
10.1016/S0140-6736(86)90837-8
10.1016/j.schres.2021.05.004
10.1093/schbul/13.2.261
10.1038/mp.2009.99
10.1093/schbul/sbq059
10.1016/j.jpsychires.2021.10.027
10.1016/j.schres.2023.07.010
ContentType Journal Article
Copyright 2024 The Authors
The Authors
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2024 The Authors
– notice: The Authors
– notice: Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.schres.2024.08.014
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 1573-2509
EndPage 68
ExternalDocumentID 39190983
10_1016_j_schres_2024_08_014
S0920996424003852
1_s2_0_S0920996424003852
Genre Journal Article
GroupedDBID ---
--K
--M
-~X
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
4H-
53G
5VS
7-5
71M
8P~
9JM
9JO
AABNK
AADFP
AAEDT
AAEDW
AAGJA
AAGUQ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABIVO
ABJNI
ABMAC
ABMZM
ABOYX
ABWVN
ABXDB
ACDAQ
ACGFS
ACHQT
ACIEU
ACIUM
ACLOT
ACRLP
ACRPL
ACVFH
ACXNI
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEG
HMK
HMO
HMQ
HMW
HVGLF
HZ~
IHE
J1W
KOM
M29
M2V
M39
M3V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OH0
OKEIE
OU-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SPS
SSB
SSH
SSN
SSY
SSZ
T5K
WUQ
Z5R
~G-
~HD
AACTN
AFCTW
RIG
6I.
AAFTH
AFKWA
AJOXV
AMFUW
9DU
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c465t-aebcfd037e8fd6d3333b22d83714a426893913e62d337c1270bfe14a55fccf253
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001302802500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0920-9964
1573-2509
IngestDate Sat Sep 27 19:27:31 EDT 2025
Wed Feb 19 01:58:22 EST 2025
Sat Nov 29 08:18:41 EST 2025
Sat Sep 14 18:12:48 EDT 2024
Fri Mar 14 01:53:02 EDT 2025
Tue Oct 14 19:26:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Video-recordings
Schizophrenia
Ratings reliability
Negative symptoms
Paired ratings
Surveillance
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c465t-aebcfd037e8fd6d3333b22d83714a426893913e62d337c1270bfe14a55fccf253
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.clinicalkey.es/playcontent/1-s2.0-S0920996424003852
PMID 39190983
PQID 3097850393
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_3097850393
pubmed_primary_39190983
crossref_primary_10_1016_j_schres_2024_08_014
elsevier_sciencedirect_doi_10_1016_j_schres_2024_08_014
elsevier_clinicalkeyesjournals_1_s2_0_S0920996424003852
elsevier_clinicalkey_doi_10_1016_j_schres_2024_08_014
PublicationCentury 2000
PublicationDate 2024-10-01
PublicationDateYYYYMMDD 2024-10-01
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Schizophrenia research
PublicationTitleAlternate Schizophr Res
PublicationYear 2024
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Kay, Opler, Fiszbein (bb0020) 1987; 13
Targum, Wedel, Bleicher, Busner, Daniel, Robinson, Rauh, Barlow (bb0060) 2013; 47
Targum, Pendergrass, Murphy (bb0085) 2021; 232
Williams, Kobak, Giller, Reasner, Curry, Detke (bb0100) 2015; 35
Murthy, Hanson, DeMartinis, Asgharnejad, Dong, Evan, Ge, Dunayevich, Singh, Ratti, Galderisi (bb0045) 2024; 270
Targum, Catania (bb0055) 2019; 14
Targum, Suppes, Pendergrass, Lee, Silva, Cucchiaro, Loebel (bb0070) 2016; 68
Verrall, Burnet, Betts, Harrison (bb0095) 2010; 15
Marder, Umbricht (bb0030) 2023; 258
Targum, Daly, Fedgchin, Cooper, Singh (bb0080) 2019; 111
Department of Health and Human Services (bb5000) 1997; 90
Murthy V, Hanson L, DeMartinis N, Asgharnejad M, Dong C, Evans R, Ge T, Dunayevich E, Singh J, Ratti E, Galderisi S. 2021. Luvadaxistat, an investigational d-amino acid oxidase inhibitor, was associated with signals of efficacy in cognitive impairment associated with schizophrenia but not negative symptoms: results from the INTERACT study. Presented at the 60th American College of Neuropsychopharmacology (ACNP) 2021 Meeting, December 5–8, 2021, San Juan, Puerto Rico.
Bland, Altman (bb0015) 1986; 1
Sheehan, Lecrubier, Sheehan (bb0050) 1998; 20
Marder, Davis, Chouinard (bb0035) 1997; 58
Kirkpatrick, Strauss, Nguyen, Fischer, Daniel, Cienfuegos (bb0025) 2011; 37
Targum, Murphy, Khan, Zumpano, Whitlock, Simen, Binneman (bb0075) 2018; 15
American Psychiatric Association (bb0010) 2013
Targum, Murphy, Breier, Paul, Brannan (bb0090) 2021; 144
World Medical Association (bb5005) 2013; 310
Targum, Pendergrass, Toner, Asgharneshad, Burch (bb0065) 2014; 24
Bland (10.1016/j.schres.2024.08.014_bb0015) 1986; 1
Marder (10.1016/j.schres.2024.08.014_bb0035) 1997; 58
10.1016/j.schres.2024.08.014_bb0040
Kirkpatrick (10.1016/j.schres.2024.08.014_bb0025) 2011; 37
Verrall (10.1016/j.schres.2024.08.014_bb0095) 2010; 15
Department of Health and Human Services (10.1016/j.schres.2024.08.014_bb5000) 1997; 90
Targum (10.1016/j.schres.2024.08.014_bb0090) 2021; 144
Targum (10.1016/j.schres.2024.08.014_bb0075) 2018; 15
Marder (10.1016/j.schres.2024.08.014_bb0030) 2023; 258
Sheehan (10.1016/j.schres.2024.08.014_bb0050) 1998; 20
Targum (10.1016/j.schres.2024.08.014_bb0070) 2016; 68
Williams (10.1016/j.schres.2024.08.014_bb0100) 2015; 35
American Psychiatric Association (10.1016/j.schres.2024.08.014_bb0010) 2013
Targum (10.1016/j.schres.2024.08.014_bb0060) 2013; 47
World Medical Association (10.1016/j.schres.2024.08.014_bb5005) 2013; 310
Kay (10.1016/j.schres.2024.08.014_bb0020) 1987; 13
Targum (10.1016/j.schres.2024.08.014_bb0085) 2021; 232
Targum (10.1016/j.schres.2024.08.014_bb0065) 2014; 24
Targum (10.1016/j.schres.2024.08.014_bb0055) 2019; 14
Targum (10.1016/j.schres.2024.08.014_bb0080) 2019; 111
Murthy (10.1016/j.schres.2024.08.014_bb0045) 2024; 270
References_xml – volume: 111
  start-page: 68
  year: 2019
  end-page: 73
  ident: bb0080
  article-title: Comparability of blinded remote and site-based assessments of response to esketamine or placebo nasal spray in patients with treatment resistant depression
  publication-title: J. Psychiatr. Res.
– volume: 47
  start-page: 944
  year: 2013
  end-page: 954
  ident: bb0060
  article-title: A comparative analysis of centralized, site-based, and patient ratings in a clinical trial of major depressive disorder
  publication-title: J. Psychiatr. Res.
– year: 2013
  ident: bb0010
  article-title: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM5)
– volume: 1
  start-page: 307
  year: 1986
  end-page: 310
  ident: bb0015
  article-title: Statistical methods for assessing agreement between two methods of clinical measurement
  publication-title: Lancet
– volume: 37
  start-page: 300
  year: 2011
  end-page: 305
  ident: bb0025
  article-title: The brief negative symptom scale: psychometric properties
  publication-title: Schizophrenia Bull
– volume: 258
  start-page: 71
  year: 2023
  end-page: 77
  ident: bb0030
  article-title: Negative symptoms in schizophrenia: newly emerging measurements, pathways, and treatments
  publication-title: Schizophr. Res.
– reference: Murthy V, Hanson L, DeMartinis N, Asgharnejad M, Dong C, Evans R, Ge T, Dunayevich E, Singh J, Ratti E, Galderisi S. 2021. Luvadaxistat, an investigational d-amino acid oxidase inhibitor, was associated with signals of efficacy in cognitive impairment associated with schizophrenia but not negative symptoms: results from the INTERACT study. Presented at the 60th American College of Neuropsychopharmacology (ACNP) 2021 Meeting, December 5–8, 2021, San Juan, Puerto Rico.
– volume: 90
  start-page: 25692
  year: 1997
  end-page: 25709
  ident: bb5000
  article-title: International Conference on Harmonization; Good Clinical Practice: Consolidated Guideline
– volume: 68
  start-page: 9
  year: 2016
  end-page: 14
  ident: bb0070
  article-title: Major depressive disorder with subthreshold hypomania (mixed features): clinical characteristics of patients entered into a multiregional, placebo-controlled study
  publication-title: Progress in Neuropsychopharmacology and Biol Psychiatry
– volume: 20
  start-page: 22
  year: 1998
  end-page: 33
  ident: bb0050
  article-title: The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
  publication-title: J. Clin. Psychiatry
– volume: 13
  start-page: 261
  year: 1987
  end-page: 276
  ident: bb0020
  article-title: The positive and negative syndrome scale (PANSS) for schizophrenia
  publication-title: Schizophr.Bull.
– volume: 310
  start-page: 2191
  year: 2013
  end-page: 2194
  ident: bb5005
  article-title: World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects
  publication-title: JAMA
– volume: 14
  year: 2019
  ident: bb0055
  article-title: Audio-digital recordings for surveillance in clinical trials of major depressive disorder
  publication-title: Contemporary Clin Trials Communications.
– volume: 15
  start-page: 122
  year: 2010
  end-page: 137
  ident: bb0095
  article-title: The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
  publication-title: Mol. Psychiatry
– volume: 270
  start-page: 249
  year: 2024
  end-page: 257
  ident: bb0045
  article-title: INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia
  publication-title: Schizophr. Res.
– volume: 144
  start-page: 241
  year: 2021
  end-page: 246
  ident: bb0090
  article-title: Site-independent confirmation of primary site based PANSS ratings in a schizophrenia trial
  publication-title: J. Psychiatr. Res.
– volume: 58
  start-page: 538
  year: 1997
  end-page: 546
  ident: bb0035
  article-title: The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the north American trials
  publication-title: J. Clin. Psychiatry
– volume: 24
  start-page: 1760
  year: 2014
  end-page: 1766
  ident: bb0065
  article-title: Audio-digital recordings used for independent confirmation of site-based MADRS interview scores
  publication-title: Eur. Neuropsychopharmacol.
– volume: 232
  start-page: 54
  year: 2021
  end-page: 60
  ident: bb0085
  article-title: Audio-digital recordings to assess ratings reliability in clinical trials of schizophrenia
  publication-title: Schizophrenia Res.
– volume: 35
  start-page: 654
  year: 2015
  end-page: 660
  ident: bb0100
  article-title: Comparison of site-based versus central ratings in a study of generalized anxiety disorder
  publication-title: J. Clin. Psychopharmacol.
– volume: 15
  start-page: 37
  year: 2018
  end-page: 42
  ident: bb0075
  article-title: Audio-digital recording for independent confirmation of clinical assessments in generalized anxiety disorder
  publication-title: Innovations in Clin Neuroscience
– volume: 270
  start-page: 249
  year: 2024
  ident: 10.1016/j.schres.2024.08.014_bb0045
  article-title: INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2024.06.017
– volume: 14
  year: 2019
  ident: 10.1016/j.schres.2024.08.014_bb0055
  article-title: Audio-digital recordings for surveillance in clinical trials of major depressive disorder
  publication-title: Contemporary Clin Trials Communications.
  doi: 10.1016/j.conctc.2019.100317
– volume: 90
  start-page: 25692
  year: 1997
  ident: 10.1016/j.schres.2024.08.014_bb5000
– volume: 68
  start-page: 9
  year: 2016
  ident: 10.1016/j.schres.2024.08.014_bb0070
  article-title: Major depressive disorder with subthreshold hypomania (mixed features): clinical characteristics of patients entered into a multiregional, placebo-controlled study
  publication-title: Progress in Neuropsychopharmacology and Biol Psychiatry
  doi: 10.1016/j.pnpbp.2016.02.007
– volume: 47
  start-page: 944
  year: 2013
  ident: 10.1016/j.schres.2024.08.014_bb0060
  article-title: A comparative analysis of centralized, site-based, and patient ratings in a clinical trial of major depressive disorder
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2013.02.016
– volume: 58
  start-page: 538
  issue: 12
  year: 1997
  ident: 10.1016/j.schres.2024.08.014_bb0035
  article-title: The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the north American trials
  publication-title: J. Clin. Psychiatry
  doi: 10.4088/JCP.v58n1205
– volume: 35
  start-page: 654
  issue: 6
  year: 2015
  ident: 10.1016/j.schres.2024.08.014_bb0100
  article-title: Comparison of site-based versus central ratings in a study of generalized anxiety disorder
  publication-title: J. Clin. Psychopharmacol.
  doi: 10.1097/JCP.0000000000000422
– volume: 24
  start-page: 1760
  year: 2014
  ident: 10.1016/j.schres.2024.08.014_bb0065
  article-title: Audio-digital recordings used for independent confirmation of site-based MADRS interview scores
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2014.08.016
– volume: 310
  start-page: 2191
  issue: 20
  year: 2013
  ident: 10.1016/j.schres.2024.08.014_bb5005
  article-title: World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects
  publication-title: JAMA
  doi: 10.1001/jama.2013.281053
– volume: 15
  start-page: 37
  issue: 3–4
  year: 2018
  ident: 10.1016/j.schres.2024.08.014_bb0075
  article-title: Audio-digital recording for independent confirmation of clinical assessments in generalized anxiety disorder
  publication-title: Innovations in Clin Neuroscience
– year: 2013
  ident: 10.1016/j.schres.2024.08.014_bb0010
– volume: 111
  start-page: 68
  year: 2019
  ident: 10.1016/j.schres.2024.08.014_bb0080
  article-title: Comparability of blinded remote and site-based assessments of response to esketamine or placebo nasal spray in patients with treatment resistant depression
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2019.01.017
– volume: 1
  start-page: 307
  year: 1986
  ident: 10.1016/j.schres.2024.08.014_bb0015
  article-title: Statistical methods for assessing agreement between two methods of clinical measurement
  publication-title: Lancet
  doi: 10.1016/S0140-6736(86)90837-8
– volume: 232
  start-page: 54
  year: 2021
  ident: 10.1016/j.schres.2024.08.014_bb0085
  article-title: Audio-digital recordings to assess ratings reliability in clinical trials of schizophrenia
  publication-title: Schizophrenia Res.
  doi: 10.1016/j.schres.2021.05.004
– volume: 13
  start-page: 261
  year: 1987
  ident: 10.1016/j.schres.2024.08.014_bb0020
  article-title: The positive and negative syndrome scale (PANSS) for schizophrenia
  publication-title: Schizophr.Bull.
  doi: 10.1093/schbul/13.2.261
– volume: 15
  start-page: 122
  issue: 2
  year: 2010
  ident: 10.1016/j.schres.2024.08.014_bb0095
  article-title: The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
  publication-title: Mol. Psychiatry
  doi: 10.1038/mp.2009.99
– volume: 20
  start-page: 22
  issue: 59 Suppl
  year: 1998
  ident: 10.1016/j.schres.2024.08.014_bb0050
  article-title: The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
  publication-title: J. Clin. Psychiatry
– volume: 37
  start-page: 300
  issue: 2
  year: 2011
  ident: 10.1016/j.schres.2024.08.014_bb0025
  article-title: The brief negative symptom scale: psychometric properties
  publication-title: Schizophrenia Bull
  doi: 10.1093/schbul/sbq059
– volume: 144
  start-page: 241
  year: 2021
  ident: 10.1016/j.schres.2024.08.014_bb0090
  article-title: Site-independent confirmation of primary site based PANSS ratings in a schizophrenia trial
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2021.10.027
– ident: 10.1016/j.schres.2024.08.014_bb0040
– volume: 258
  start-page: 71
  year: 2023
  ident: 10.1016/j.schres.2024.08.014_bb0030
  article-title: Negative symptoms in schizophrenia: newly emerging measurements, pathways, and treatments
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2023.07.010
SSID ssj0001507
Score 2.451824
Snippet Site-independent ratings derived from audio-digital recordings of site-based interviews are often used for quality assurance monitoring to affirm ratings...
AbstractSite-independent ratings derived from audio-digital recordings of site-based interviews are often used for quality assurance monitoring to affirm...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 61
SubjectTerms Adult
Female
Humans
Interview, Psychological - standards
Male
Middle Aged
Negative symptoms
Paired ratings
Psychiatric Status Rating Scales - standards
Psychiatric/Mental Health
Quality Assurance, Health Care - standards
Ratings reliability
Reproducibility of Results
Schizophrenia
Schizophrenia - diagnosis
Schizophrenia - physiopathology
Schizophrenic Psychology
Surveillance
Video-recordings
Title Use of video-recordings of site-based interviews for quality assurance in a study of subjects with schizophrenia and persistent negative symptoms
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0920996424003852
https://www.clinicalkey.es/playcontent/1-s2.0-S0920996424003852
https://dx.doi.org/10.1016/j.schres.2024.08.014
https://www.ncbi.nlm.nih.gov/pubmed/39190983
https://www.proquest.com/docview/3097850393
Volume 272
WOSCitedRecordID wos001302802500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1573-2509
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001507
  issn: 0920-9964
  databaseCode: AIEXJ
  dateStart: 20210201
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfKxgMvCMS_MpiMxFuVKU3iJnmcYAiQmJDWSX2zHNvp1oFTJe207Vvwcfh23NlO2q1MDCT6EFVOHTe5X3zn893vCHmrYqbyUOpAhHEZJEWZBZnUKrCJkEwrUDvSFptIDw-zyST_2uv9bHNhzr-lxmQXF_n8v4oa2kDYmDr7F-LuLgoN8B2EDkcQOxzvJPhj553H_LoqcD4YW5oT2nCnOEC9pSxNRG2JSG2gocutvByAKb2sbRbBqRkIRz5rey6LmY37cCHt65F6jmoA3W4AGLMYGD11ZOLN5ff5ovJs6N7-PbrW0zMNdR7psainru6yK7Y2eL_XxQc5dmCM92-VLcK0mZ6I2uiZA-oXcWLEVbeHpM-aChXErPKRyLVYd3JESRcu5z1vG9k3zoUJS19YryXrs3nkKgH5-dgRvXvN7ur3bOgM576YoTcBbnsPh7esri659QYb9xEOimNi7G2cMdD-21HKcphQt_c_HUw-d2YAWtqW6NH_yTZv0wYXbo51m11027rH2j_jR-ShX7jQfQe4x6SnzRPyA8BGq5LeBBu2rcBGV2CjADbqwUY7sMEPqKAWbLanBxtFsNFrYKMANroCG23BRluwPSXHHw7G7z4GvshHIJMRWwRCF7JUYZzqrFQjFcOniCKVIZOkAPMR7Ol8GOtRBKdSiXESRanhFGOllGXE4mdky1RGvyA0TCUsfkEFK5YnScmEDGMNolG5KjLJoj4J2kfM547LhbdBjjPuRMJRJBwrsw6TPmGtHHibpwyalQNw_tAv_V0_3fhZouFD3kQ85BtgWu_pLWBn2d5hzDctUDgoCNz1E0ZXy4bHmKnFMAW_T547BHV3D482D_MsfvnP4-6QB6v39RXZWtRL_Zrcl-eL06beJffSSbbr34xfhPP2fg
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+video-recordings+of+site-based+interviews+for+quality+assurance+in+a+study+of+subjects+with+schizophrenia+and+persistent+negative+symptoms&rft.jtitle=Schizophrenia+research&rft.au=Targum%2C+Steven+D.&rft.au=Ge%2C+Tingting&rft.au=Asgharnejad%2C+Mahnaz&rft.au=Reksoprodjo%2C+Petra&rft.date=2024-10-01&rft.pub=Elsevier+B.V&rft.issn=0920-9964&rft.volume=272&rft.spage=61&rft.epage=68&rft_id=info:doi/10.1016%2Fj.schres.2024.08.014&rft.externalDocID=S0920996424003852
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09209964%2FS0920996424X00092%2Fcov150h.gif